Cambium Bio LtdASX: CMB

Notification of cessation of securities - CMB

Sep 23, 2026 at 7:11 PM EDT · Issued by Cambium Bio Ltd via ASX

Filed with ASX · Sep 23, 2026 at 7:11 PM EDT · 4 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-cmb

Release

Appendix 3H - Notification of cessation of securitiesAppendix 3H - Notification of cessation of securities1 / 4Announcement SummaryEntity nameCAMBIUM BIO LIMITEDAnnouncement TypeNew announcementDate of this announcementThursday September 24, 2026Details of +securities that have ceasedASX...

Cambium Bio Ltd on 6ix

Earlier from Cambium Bio

Notification regarding unquoted securities - CMBSep 22
Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye DiseaseSep 16
Cambium Bio Secures A$10.85 Million Funding PackageSep 15
Proposed issue of securities - CMBSep 15
Notice of ceasing to be a substantial holderSep 15

Later from Cambium Bio

Date of AGM and Closing Date for Director NominationsSep 27
Corporate Presentation - September 2026Sep 29
Notice of Annual General Meeting and Proxy formOct 7
Access Letter and Online Meeting GuideOct 7
Quarterly Activities/Appendix 4C Cash Flow ReportOct 28

All Cambium Bio news releases

Follow Cambium Bio into a list and get an email when it puts out news.

Follow Cambium Bio